ALBERTO QUEIROZ FARIAS

(Fonte: Lattes)
Índice h a partir de 2011
12
Lattes
ResearcherID
ORCID
Projetos de Pesquisa
Unidades Organizacionais
Departamento de Gastroenterologia, Faculdade de Medicina - Docente
Instituto Central, Hospital das Clínicas, Faculdade de Medicina - Médico

Filtros

Limpar filtros

Configurações

Autor e Coautores FMUSP-HC Normalizados: FERNANDO BACAL ×

Resultados de Busca

Agora exibindo 1 - 10 de 13
  • conferenceObject
    Clinical predictors of primary cardiopathies in liver transplantation candidates
    (2013) SILVESTRE, O. M.; FARIAS, A. Q.; RAMOS, D. S.; ZITELLI, P. M. Y.; FURTADO, M. S.; ANDRADE, J. L.; XIMENES, R. O.; CARRILHO, F. J.; D'ALBUQUERQUE, L. A. C.; BACAL, F.
  • article 26 Citação(ões) na Scopus
    Impact of the severity of end-stage liver disease in cardiac structure and function
    (2013) SILVESTRE, Odilson Marcos; BACAL, Fernando; RAMOS, Danusa de Souza; ANDRADE, Jose L.; FURTADO, Meive; PUGLIESE, Vincenzo; BELLETI, Elisangela; ANDRAUS, Wellington; CARRILHO, Flair Jose; D'ALBUQUERQUE, Luiz Augusto Carneiro; FARIAS, Alberto Queiroz
    Background. The impact of end-stage liver disease (ESLD) in cardiac remodeling of patients with cirrhosis is unknown. Our aim was to correlate the severity of ESLD with morphologic and functional heart changes. Material and methods. 184 patients underwent a protocol providing data on the severity of ESLD and undergoing echocardiography to assess the diameters of the left atrium and right ventricle; the systolic and diastolic diameters of the left ventricle, interventricular septum, and posterior wall of the left ventricle; systolic pulmonary artery pressure; ejection fraction; and diastolic function. Severity of ESLD was assessed by the Model for End-Stage Liver Disease (MELD) score. Results. Left-atrial diameter (r = 0.323; IC 95% 0.190-0.455; p < 0.001), left-ventricular diastolic diameter (r = 0.177; IC 95% 0.033-0.320; p = 0.01) and systolic pulmonary artery pressure (r = 0.185; IC 95% 0.036-0.335; p = 0.02) significantly correlated with MELD score. Patients with MELD 16 had significantly higher left-atrial diameter and systolic pulmonary artery pressure, compared with patients with MELD scores < 16 points. Conclusions. Changes in cardiac structure and function correlate with the severity of ESLD.
  • article 9 Citação(ões) na Scopus
    Early-Onset and Late-Onset Heart Failure After Liver Transplantation
    (2014) SILVESTRE, Odilson M.; FARIAS, Alberto Q.; BACAL, Fernando
  • article 0 Citação(ões) na Scopus
    Cardiac Dysfunction Related to Cirrhosis
    (2013) SILVESTRE, Odilson Marcos; FARIAS, Alberto Queiroz; BACAL, Fernando
  • article 0 Citação(ões) na Scopus
    Serum B-type natriuretic peptide in the initial workup of patients with new onset ascites: A diagnostic accuracy study (vol 59, pg 1043. 2014)
    (2014) FARIAS, Alberto Q.; SILVESTRE, Odilson M.; GARCIA-TSAO, Guadalupe; SEGURO, Luis F. B. da Costa; MAZO, Daniel F. de Campos; BACAL, Fernando; ANDRADE, Jose L.; GONCALVES, Luciana L.; STRUNZ, Celia; RAMOS, Danusa S.; POLLI, Demerson; PUGLIESE, Vincenzo; RODRIGUES, Ana C. T.; FURTADO, Meive S.; CARRILHO, Flair J.; D'ALBUQUERQUE, Luiz A. C.
  • conferenceObject
    Serum B-type natriuretic peptide is more accurate than ascites analyses in the diagnosis of ascites related to heart failure
    (2013) FARIAS, A. Q.; SILVESTRE, O. M.; BACAL, F.; GARCIA-TSAO, G.; SEGURO, L. F. B. C.; MAZO, D. F. C.; ANDRADE, J. L.; FURTADO, M. S.; CARRILHO, F. J.; D'ALBUQUERQUE, L. A. C.
  • article 12 Citação(ões) na Scopus
    Transcatheter Aortic Valve Implantation as Rescue Therapy for Liver Transplant Candidates With Aortic Valve Stenosis
    (2014) SILVESTRE, Odilson Marcos; BACAL, Fernando; RAMOS, Danusa Souza; TARASOUTCHI, Flavio; ACORSI, Tarso D.; FERNANDES, Fabio; LEMOS, Pedro A.; CARRILHO, Flair Jose; D'ALBUQUERQUE, Luiz A. C.; FARIAS, Alberto Queiroz
  • article 23 Citação(ões) na Scopus
    beta-Blocker therapy for cirrhotic cardiomyopathy: a randomized-controlled trial
    (2018) SILVESTRE, Odilson M.; FARIAS, Alberto Q.; RAMOS, Danusa S.; FURTADO, Meive S.; RODRIGUES, Ana C.; XIMENES, Rafael O.; MAZO, Daniel F. de Campos; ZITELLI, Patricia M. Yoshimura; DINIZ, Marcio A.; ANDRADE, Jose L.; STRUNZ, Celia; FRIEDMANN, Antonio A.; LEE, Samuel S.; CARRILHO, Flair J.; D'ALBUQUERQUE, Luiz A. C.; BACAL, Fernando
    Background Cirrhotic cardiomyopathy is characterized by an attenuated contractile response to stress. Long-term exposure of beta-adrenergic receptors to persistently high levels of catecholamines has been implicated in its pathogenesis. We hypothesized that beta-blockade with metoprolol could reverse the changes in heart function and morphology in cirrhotic cardiomyopathy. Patients and methods In this prospective randomized trial, we included 78 patients aged between 18 and 60 years with abnormal cardiac output response under dobutamine stress echocardiography, without primary cardiac disease or a history of alcohol intake. Patients were assigned randomly to receive metoprolol or placebo for 6 months. The primary endpoint was the improvement in cardiac output response to stress, measured by an increase in the left ventricle stroke volume more than 30%. Results Three (7.3%) patients in the metoprolol group and nine (24.3%) patients in the placebo group showed improved stroke volume (P=0.057). Diastolic dysfunction was found in two (4.8%) patients before and in five (15.6%) patients after therapy in the metoprolol group, and in 10 (27%) patients before and nine (31%) patients after therapy in the placebo group (P=0.67). After treatment, no echocardiography parameter of morphology was significantly different between metoprolol or placebo groups. No significant differences were observed in noradrenaline, plasma renin activity, and troponin levels between groups. Cirrhosis-related clinical events, including hospitalizations and mortality, were not significantly different between the two groups. Six months of therapy with beta-blocker did not ameliorate heart function and morphology in patients with cirrhotic cardiomyopathy.
  • conferenceObject
    Impact of the Severity of End-Stage Liver Disease in Cardiac Remodeling
    (2012) SILVESTRE, O. M.; BACAL, F.; FARIAS, A. Q.; ANDRADE, J. L.; FURTADO, M.; PUGLIESE, V.; ANDRAUS, W.; RAMOS, D. S.; BELLETI, E.; ALBUQUERQUE, L. A. C.; CARRILHO, F. J.
    Purpose: The impact of end-stage liver disease (ESLD) in cardiac remodeling of patients with cirrhosis is unknown. Our aim was to correlate the severity of ESLD with morphologic and functional heart changes. Methods and Materials: 184 patients underwent a protocol providing data on the severity of ESLD and undergoing echocardiography to assess the diameters of the left atrium and right ventricle; the systolic and diastolic diameters of the left ventricle, interventricular septum, and posterior wall of the left ventricle; systolic pulmonary artery pressure; ejection fraction; and diastolic function. Severity of ESLD was assessed by the Model for End-Stage Liver Disease (MELD) score. Results: Left-atrial diameter (r=0.323; IC 95% 0.190-0.455; p<0.001), left-ventricular diastolic diameter (r=0.177; IC 95% 0.033-0.320; p=0.01) and systolic pulmonary artery pressure (r=0.185; IC 95% 0.036-0.335; p=0.02) significantly correlated with MELD score. Patients with MELD >16 had significantly higher left-atrial diameter and systolic pulmonary artery pressure, compared with patients with MELD scores <16 points. Conclusions: Changes in cardiac structure and function correlate with the severity of ESLD.
  • article 4 Citação(ões) na Scopus
    Cardiohepatic Interactions - from Humoral Theory to Organ Transplantation
    (2014) SILVESTRE, Odilson Marcos; BACAL, Fernando; XIMENES, Rafael Oliveira; CARRILHO, Flair Jose; D'ALBUQUERQUE, Luiz Augusto Carneiro; FARIAS, Alberto Queiroz